SYP and stroke disorder: APX3330 significantly promotes myelin density (p<0.05, n=7/group, Fig. 3A) and synaptophysin expression (p<0.05, n=7/group, Fig. 3B) in the IBZ compared to PBS treated control T1DM stroke rats.